The Patent Finder

Terms ending in 2039

Astellas Pharma Inc.

Every in-force patent on Astellas Pharma Inc.'s record whose computed term ends in 2039, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleHolderStatusExpiresConfidence
US 11,679,166Novel Anti-Human MUC1 Antibody Fab Fragment
In force
 · Low confidence
Astellas Pharma Inc.In forceLow confidence
US 11,787,862Bispecific Trivalent Antibodies Binding to CLAUDIN6 or CLAUDIN18.2 and CD3 for Treatment of Claudin Expressing Cancer Diseases
In force
 · High confidence
BioNTech SEIn forceHigh confidence
US 11,638,730Cancer Therapy by Combination Use of Oncolytic Vaccinia Virus and Immune Checkpoint Inhibitor, and Pharmaceutical Composition and Combination Medicine for Use in the Cancer Therapy
In force
 · High confidence
Astellas Pharma Inc.In forceHigh confidence
US 11,473,071Method for Treating Muscular Dystrophy by Targeting Utrophin Gene
In force
 · High confidence
Modalis Therapeutics CorporationIn forceHigh confidence
US 11,578,067Novel Compound, And Method For Producing Regulatory T Cells
In force
 · High confidence
Kyoto UniversityIn forceHigh confidence
US 11,667,724Novel Anti-Human CEACAM5 Antibody Fab Fragment
In force
 · High confidence
Astellas Pharma Inc.In forceHigh confidence
6 of 6 patents shown. Soonest term end first, then patent number.
3 of these are in force and held by Astellas Pharma Inc..
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited